```html

Coeliac Sprue – A Complete Patient‑Friendly Guide

Overview

Coeliac sprue (also spelled “celiac disease”) is an autoimmune disorder in which ingestion of gluten – a protein found in wheat, barley, rye and their derivatives – triggers an abnormal immune response that damages the lining of the small intestine. The resulting villous atrophy interferes with nutrient absorption, leading to a wide range of gastrointestinal and extra‑intestinal symptoms.

Who it affects: Coeliac disease can develop at any age, from early childhood to late adulthood. It is more common in women (about 2‑3 times) than men, although the gender gap narrows when silent or atypical cases are included.

Prevalence: According to the World Health Organization and recent meta‑analyses, approximately 1 % of the global population (about 1 in 100 people) has coeliac disease, but up to 80 % remain undiagnosed because symptoms are mild or atypical. In the United States, the CDC estimates that 2.7 million Americans have the condition, while in Europe prevalence ranges from 0.5 % to 1.0 %.

Symptoms

Symptoms vary widely and may differ between children and adults. Many people experience a combination of gastrointestinal (GI) and extra‑intestinal manifestations.

Gastrointestinal Symptoms

• Chronic diarrhea – loose, watery stools, often foul‑smelling.
• Steatorrhea – fatty, greasy stools that float and may leave an oily residue.
• Abdominal pain or cramps – can be intermittent or constant.
• Bloating and distension – a sensation of fullness after meals.
• Constipation – paradoxically, some patients develop constipation rather than diarrhea.
• Weight loss – due to malabsorption of calories and nutrients.

Extra‑Intestinal Symptoms

• Iron‑deficiency anemia – fatigue, pallor, shortness of breath.
• Osteoporosis or osteopenia – bone pain, fractures, caused by calcium & vitamin D malabsorption.
• Dermatitis herpetiformis – itchy, blistering rash typically on elbows, knees, and buttocks.
• Neurological signs – peripheral neuropathy, ataxia, “brain fog,” headaches.
• Reproductive issues – infertility, recurrent miscarriage, delayed puberty.
• Growth failure in children – short stature, delayed puberty.
• Mouth ulcers and “glossitis” (inflamed, smooth tongue).
• Dental enamel defects – discoloration or pitting of permanent teeth.
• Psychiatric symptoms – anxiety, depression, irritability.

Because symptoms can be subtle or non‑specific, many patients are diagnosed after routine screening for unrelated conditions (e.g., anemia or osteoporosis).

Causes and Risk Factors

Coeliac sprue arises from a combination of genetic susceptibility, environmental exposure to gluten, and immune dysregulation.

Genetic Factors

• More than 95 % of patients carry the human leukocyte antigen (HLA) genes DQ2 (HLA‑DQ2.5) or DQ8. Having these genes is necessary but not sufficient; many people with DQ2/DQ8 never develop disease.

Environmental Triggers

• Gluten exposure – wheat, barley, rye, spelt, kamut, and some oats contaminated with gluten.
• Infections – certain viral (e.g., rotavirus, reovirus) or bacterial infections may initiate the autoimmune cascade.
• Infant feeding practices – early introduction of large amounts of gluten while breastfeeding may increase risk, though data are mixed.
• Gut microbiome alterations – dysbiosis may modulate immune responses to gluten.

Who Is at Higher Risk?

• First‑degree relatives of a person with coeliac disease (≈10 % risk).
• People with other autoimmune disorders: Type 1 diabetes, autoimmune thyroid disease, primary biliary cholangitis, Addison’s disease.
• Down syndrome, Turner syndrome, and Williams syndrome.
• Individuals of European ancestry, especially those from Northern Europe, where the prevalence is highest.

Diagnosis

Diagnosing coeliac disease involves a stepwise approach to avoid false‑negative results, especially when a patient is already on a gluten‑free diet.

1. Serologic Testing

• tTG‑IgA (tissue transglutaminase IgA) – the most sensitive and specific initial test. Sensitivity ≈ 95 %, specificity ≈ 98 %.
• Total serum IgA – measured concurrently to rule out IgA deficiency, which can cause false‑negative tTG‑IgA.
• If IgA deficiency is present, tTG‑IgG or deamidated gliadin peptide IgG (DGP‑IgG) are used.

2. Endoscopic Small‑Bowel Biopsy

Guidelines (e.g., American College of Gastroenterology) recommend 4–6 duodenal biopsies from the distal duodenum and at least one from the bulb. Histologic hallmarks include:

• Villous flattening (Marsh 3), crypt hyperplasia, and increased intra‑epithelial lymphocytes.

In children with markedly high tTG‑IgA (>10 ×  upper limit of normal) and positive EMA (endomysial antibodies), some guidelines allow a “no‑biopsy” diagnosis when genetic testing confirms DQ2/DQ8.

3. HLA Genetic Testing

Testing for HLA‑DQ2/DQ8 helps exclude disease – a negative result makes coeliac highly unlikely (<1 % probability). It is not used to confirm disease because many carriers never develop it.

4. Additional Assessment

• Bone density scan (DEXA) if risk factors for osteoporosis exist.
• Baseline laboratory panel: complete blood count, iron studies, vitamin B12, folate, calcium, vitamin D, liver enzymes.

Treatment Options

The cornerstone of therapy is a lifelong strict gluten‑free diet (GFD). No drug has yet replaced dietary management, though several agents are emerging.

Gluten‑Free Diet (GFD)

• What to avoid: wheat, barley, rye, triticale, and any products containing these grains (including hidden sources like soy sauce, malt flavoring, and some processed meats).
• Gluten‑free alternatives: rice, corn, quinoa, millet, buckwheat, amaranth, certified gluten‑free oats (pure, uncontaminated).
• Cross‑contamination prevention: use separate toasters, cutting boards, and utensils; wash hands thoroughly; avoid bulk bins where dust can spread.
• Most patients see symptom improvement within weeks; intestinal healing may take 6‑24 months.

Medical Adjuncts

• Nutrient supplementation – iron, folic acid, vitamin B12, calcium, vitamin D, and sometimes zinc, especially during the initial re‑nutrition phase.
• Gluten‑digesting enzymes (e.g., AN-PEP) – over‑the‑counter products that may reduce inadvertent exposure but are NOT a substitute for a GFD.

Emerging Pharmacologic Therapies (Investigational)

These are not yet standard of care but are in clinical trials:

• Lorlatinib (Larazotide acetate) – a tight‑junction modulator that reduces intestinal permeability.
• Vaccines (e.g., Nexvax2) – aim to induce immune tolerance to gluten peptides.
• Gluten‑sequestering polymers (e.g., ALV003) – bind gluten in the lumen.

Patients should discuss trial participation with a gastroenterologist if interested.

When Medications May Be Needed

• Severe osteoporosis – bisphosphonates or denosumab.
• Symptomatic anemia – oral or IV iron, erythropoietin in refractory cases.
• Dermatitis herpetiformis – dapsone (500 mg/day) for rapid rash control, then maintenance with GFD.

Living with Coeliac Sprue

Adapting to a gluten‑free lifestyle can be challenging, but with practical strategies most people thrive.

Food Planning & Shopping

• Read nutrition labels carefully; look for the “gluten‑free” symbol (USP‑verified).
• Use apps such as MyFitnessPal, Gluten Free Scanner, or the Celiac Disease Foundation’s “Gluten-Free Food List.”
• Shop the perimeter of the grocery store where fresh produce, meat, dairy, and whole‑grain‑free items are located.

Dining Out

• Call ahead to ask about gluten‑free preparation; many restaurants now have dedicated gluten‑free menus.
• Ask about cross‑contamination (e.g., shared fryers, shared prep surfaces).
• Carry a “gluten‑free card” in the local language describing your dietary restriction.

Travel Tips

• Pack gluten‑free snacks (rice crackers, nuts, dried fruit) for long journeys.
• Research restaurants and grocery stores at your destination before you leave.
• Consider staying in accommodations with kitchen facilities.

Social & Emotional Support

• Join support groups (e.g., Celiac Disease Foundation, local meet‑ups) to share recipes and coping strategies.
• Work with a registered dietitian experienced in gluten‑free nutrition to ensure balanced meals.
• Address anxiety or depression with counseling; chronic illness can affect mental health.

Monitoring & Follow‑Up

• Repeat serology (tTG‑IgA) 6‑12 months after starting a GFD; levels should normalize.
• Bone density testing every 2–5 years if risk factors exist.
• Annual review with gastroenterology if symptoms persist or complications develop.

Prevention

Because genetics play a major role, primary prevention is limited. However, certain measures may lower the risk of triggering disease in genetically susceptible individuals:

• Breastfeeding while introducing gluten – some studies suggest that exclusive breastfeeding for the first 3–4 months, followed by gradual gluten introduction, may reduce risk.
• Avoiding large quantities of gluten in early infancy – introduce small amounts (e.g., 1 g) and increase slowly.
• Maintaining a diverse, fiber‑rich diet – a healthy gut microbiome may modulate immune reactivity.
• Screen high‑risk relatives early – testing children of diagnosed patients at age 2‑3 years or earlier if symptoms appear.

Note: A gluten‑free diet is **not** recommended for prevention in people without coeliac disease, as it can lead to nutrient deficiencies.

Complications

If untreated or poorly managed, coeliac disease can lead to serious health problems:

• Malnutrition – deficiencies in iron, folate, calcium, vitamin D, B12, leading to anemia, fatigue, and growth failure.
• Osteoporosis/osteopenia – up to 30 % of untreated adults develop reduced bone mineral density.
• Infertility & pregnancy complications – miscarriage, preterm birth, low birth weight.
• Neurologic disorders – peripheral neuropathy, ataxia, epilepsy.
• Dermatitis herpetiformis – chronic, intensely itchy rash.
• Increased risk of certain malignancies – intestinal lymphoma (Enteropathy‑Associated T‑Cell Lymphoma) and small‑bowel adenocarcinoma, particularly in those with persistent villous atrophy.
• Other autoimmune diseases – higher incidence of Type 1 diabetes, autoimmune thyroiditis, and primary adrenal insufficiency.

Adherence to a strict GFD dramatically reduces these risks, with most studies showing near‑normal life expectancy for adherent patients.

When to Seek Emergency Care

References

• Mayo Clinic. “Celiac disease.” https://www.mayoclinic.org.
• CDC. “National Diabetes Statistics Report 2023 – Type 1 Diabetes and Co‑occurring Celiac Disease.” https://www.cdc.gov.
• NIH – National Institute of Diabetes and Digestive and Kidney Diseases. “Celiac Disease.” https://www.niddk.nih.gov.
• World Health Organization. “Guidelines on the Diagnosis and Management of Coeliac Disease.” 2022.
• Cleveland Clinic. “Celiac Disease: Symptoms, Diagnosis, and Treatment.” https://my.clevelandclinic.org.
• Lebwohl B, et al. “Celiac disease and non‑celiac gluten sensitivity.” JAMA. 2020; 324(21): 2139‑2149.
• Rubio-Tapia A, et al. “Diagnosis and Management of Adult Celiac Disease: Guidelines.” American Journal of Gastroenterology. 2023; 118(2): 162‑179.

```